title: In utero lung gene transfer using adeno-associated viral and lentiviral vectors in mice.
abstract: Virus-mediated gene transfer to the fetal lung epithelium holds considerable promise for the therapeutic management of prenatally diagnosed, potentially life-threatening inherited lung diseases. In this study we hypothesized that efficient and life-long lung transduction can be achieved by in utero gene therapy, using viral vectors. To facilitate diffuse entry into the lung, viral vector was injected into the amniotic sac of C57BL/6 mice on embryonic day 16 (term, ∼ 20 days) in a volume of 10 μl. Vectors investigated included those based on adeno-associated virus (AAV) (serotypes 5, 6.2, 9, rh.64R1) and vesicular stomatitis virus G glycoprotein (VSV-G)-pseudotyped HIV-1-based lentivirus (LV). All vectors expressed green fluorescent protein (GFP) under the transcriptional control of various promoters including chicken β-actin (CB) or cytomegalovirus (CMV) for AAV and CMV or MND (myeloproliferative sarcoma virus enhancer, negative control region deleted) for LV. Pulmonary GFP gene expression was detected by fluorescence stereoscopic microscopy and immunohistochemistry for up to 9 months after birth. At equivalent vector doses (mean, 12 × 10(10) genome copies per fetus) three AAV vectors resulted in long-term (up to 9 months) pulmonary epithelium transduction. AAV2/6.2 transduced predominantly cells of the conducting airway epithelium, although transduction decreased 2 months after vector delivery. AAV2/9-transduced cells of the alveolar epithelium with a type 1 pneumocyte phenotype for up to 6 months. Although minimal levels of GFP expression were observed with AAV2/5 up to 9 months, the transduced cells immunostained positive for F480 and were retrievable by bronchoalveolar lavage, confirming an alveolar macrophage phenotype. No GFP expression was observed in lung epithelial cells after AAV2/rh.64R1 and VSV-G-LV vector-mediated gene transfer. We conclude that these experiments demonstrate that prenatal lung gene transfer with AAV vectors engineered to target pulmonary epithelial cells may provide sustained long-term levels of transgene expression, supporting the therapeutic potential of prenatal gene transfer for the treatment of congenital lung diseases.
authors.affiliation: 1 Children's Center for Fetal Research, Children's Hospital of Philadelphia , Philadelphia, PA 19104.
authors.forename: Luc
authors.initials: L
authors.lastname: Joyeux
authors.forename: Enrico
authors.initials: E
authors.lastname: Danzer
authors.forename: Maria P
authors.initials: MP
authors.lastname: Limberis
authors.forename: Philip W
authors.initials: PW
authors.lastname: Zoltick
authors.forename: Antoneta
authors.initials: A
authors.lastname: Radu
authors.forename: Alan W
authors.initials: AW
authors.lastname: Flake
authors.forename: Marcus G
authors.initials: MG
authors.lastname: Davey
mesh_terms: D000199:Actins / Q000235:genetics; D056809:Alveolar Epithelial Cells / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D002645:Chickens; D003587:Cytomegalovirus / Q000235:genetics; D000229:Dependovirus / Q000235:genetics*; D005260:Female; D005822:Genetic Vectors / Q000235:genetics / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D016086:Lentivirus / Q000235:genetics*; D008168:Lung / Q000378:metabolism*; D008264:Macrophages; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D011401:Promoter Regions, Genetic; D014161:Transduction, Genetic
chemical_list: D000199:Actins; D008562:Membrane Glycoproteins